On Cancer: Cancer Immunotherapy & Vaccines

and/or

62 Blog posts found

Feature

For One MSK Researcher, Science Is as Mighty as the Sword

Learn about Gabe Armijo, a researcher in the Sloan Kettering Institute and a competitive fencer.

Gabe Armijo in full fencing gear

In the News

AACR 2019 Research Roundup: Nanosensors for Cancer, New Immunotherapy Targets, a Road Map of Metastasis, and CAR T Fratricide

Read our key takeaways from the second half of the American Association for Cancer Research’s 2019 annual meeting.

an illustration of cancer metastasis

In the News

AACR 2019 Research Roundup: Pancreatic Cancer Immunotherapy, Prostate Cancer Drug Resistance, Insight into Inherited Cancer Mutations

Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.

AACR 2019 Annual Meeting

In the Lab

Retooled CAR T Cells Lock in on New Multiple Myeloma Target

Researchers have redesigned CAR T cells in hopes of improving immunotherapy treatment for multiple myeloma.

Light micrograph of multiple myeloma cells.

Q & A

Helping Hispanics Prevent HPV-Related Cancers: 6 Questions with an MSK Expert

Learn more about HPV and cancer risk in the Hispanic community, which has more cancers linked to the disease than any other group in the United States.

Nurse bandaging patient after vaccination

Q & A

HPV Testing and Pap Smears: Understanding the Latest Guidelines for Cervical Cancer Screening

Learn about the latest guidelines for Pap tests, HPV tests, and pelvic exams — including recently updated recommendations.

Deborah Goldfrank

In the Lab

CAR T Cells Get an Invisibility Cloak

Research is focusing on ways to help cancer-fighting immune cells stick around longer, boosting their effectiveness.

A cartoon of a person hiding behind a newspaper and sunglasses.

Finding

Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.

Tumor mutation model

In the Lab

Drugs That Stall — But Don’t Kill — Cancer Cells Are an Untapped Resource, Study Suggests

A drug combination that halts tumor cell division can stir the immune system into taking action.

electron micrograph of a natural killer cell

In the Lab

MSK Scientists Fine-Tune CAR T Cells to Improve Their Performance

The updated versions can survive longer in the body while still packing a punch against cancer.

Illustration of mechanical arms altering a cell